What were Sai Parenterals Ltd's latest quarterly results?
Sai Parenterals Ltd's latest quarterly results (Mar 2026) show
- Operating Margin: 13.0%
Sai Parenterals Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +34.1%New This Week
In , Sai Parenterals Ltd (Pharma - Formulators) is outperforming Nifty 500 with +34.1% relative strength.
Sai Parenterals Ltd Key Facts
- RS vs Nifty 500
- +34.1%
What's Happening
📊Debt increased 254% YoY — leverage rising
Key Numbers
Current Price
₹619
Market Cap
2.6K Cr
Valuation
N/A12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
Other Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Sai Parenterals Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Sai Parenterals Ltd's current PE ratio?
Sai Parenterals Ltd's current PE ratio is 192.0x.
- Current PE: 192.0x
- Market Cap: 2.7K Cr
Is Sai Parenterals Ltd a fundamentally strong company?
Sai Parenterals Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 6.0%
Is Sai Parenterals Ltd debt free?
Sai Parenterals Ltd's debt position
- Total Debt: ₹333 Cr
What is Sai Parenterals Ltd's return on equity (ROE) and ROCE?
Sai Parenterals Ltd's return ratios over recent years
- FY2024: ROCE 16.0%
- FY2025: ROCE 17.0%
- FY2026: ROCE 6.0%
Is Sai Parenterals Ltd's cash flow positive?
Sai Parenterals Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹93 Cr
- Free Cash Flow (FCF): ₹-181 Cr
- CFO/PAT Ratio: 664% (strong cash conversion)
What is Sai Parenterals Ltd's dividend yield?
Sai Parenterals Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹619
Who holds Sai Parenterals Ltd shares — promoters, FII, DII?
Sai Parenterals Ltd's shareholding pattern (Apr 2026)
- Promoters: 51.2%
- FII (Foreign): 5.7%
- DII (Domestic): 12.9%
- Public: 30.3%
Is promoter holding increasing or decreasing in Sai Parenterals Ltd?
Sai Parenterals Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 51.2% (Apr 2026)
- Previous Quarter: 51.2% (Mar 2026)
- Change: 0.00% (stable)
How long has Sai Parenterals Ltd been outperforming Nifty 500?
Sai Parenterals Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.
Is Sai Parenterals Ltd a new momentum entry or an established outperformer?
Sai Parenterals Ltd is a new entry this week — it just started outperforming Nifty 500. New entries are worth monitoring for follow-through.
Is Sai Parenterals Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Sai Parenterals Ltd may be worth studying
- Cash flow is positive — CFO ₹93 Cr
What is the investment thesis for Sai Parenterals Ltd?
Sai Parenterals Ltd investment thesis summary:
What is the future outlook for Sai Parenterals Ltd?
Sai Parenterals Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.